Study for Investigate the Effectiveness and Safety of Resolute Integrity or Xience Prime in Diabetes or Small Vessels Lesion Patients
Latest Information Update: 24 May 2020
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris
- Focus Therapeutic Use
- Acronyms COPERES
- 30 Mar 2020 Primary endpoint has been met. (target lesion revascularization (TLR))
- 30 Mar 2020 Status has been changed to completed.
- 30 Mar 2020 Results comapring everolimus-eluting stents and zotarolimus-eluting stents Patients with Diabetes Mellitus and Small Vessel Disease, presented at the 2020 Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology